CARSTEN BOESS Insider Trading
Get free email notifications about insider trading for CARSTEN BOESS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARSTEN BOESS. CARSTEN BOESS is a SVP, Chief Financial Officer in SYNAGEVA BIOPHARMA CORP ($GEVA).
Address: 33 HAYDEN AVE LEXINGTON 02421 MA
Companies in which CARSTEN BOESS is an Insider
SYNAGEVA BIOPHARMA CORP
Trading Symbol: GEVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CARSTEN BOESS: SVP, Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Feb 19 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CARSTEN BOESS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | M | 40.74 | 29,062 | 1,183,986 | 15,938 | |
Feb 19 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | M | 1.70 | 13,235 | 22,500 | 9,929 | |
Feb 19 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | S | 101.69 | 1,842 | 187,313 | 0 | 1.8 K to 0 (-100.00 %) |
Feb 19 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | S | 100.74 | 16,716 | 1,683,970 | 1,842 | 18.6 K to 1.8 K (-90.07 %) |
Feb 19 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | S | 99.97 | 14,750 | 1,474,558 | 18,558 | 33.3 K to 18.6 K (-44.28 %) |
Feb 19 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | S | 98.85 | 8,989 | 888,563 | 33,308 | 42.3 K to 33.3 K (-21.25 %) |
Feb 19 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Buy | M | 40.74 | 29,062 | 1,183,986 | 42,297 | 13.2 K to 42.3 K (+219.58 %) |